Diligence memo · auto-generated · as of July 2, 2026
Hazel Health, Inc.
Hazel Health, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Hazel Health, Inc. operates in Healthtech, based in Irving.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Hazel Health, Inc. has raised $86M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $51M on 2022-03-25.
Most recent recorded round closed around 2022-03-25.
Valuation (modeled)modeled
Provath models Hazel Health, Inc. at approximately $818M (range $187M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.68× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 22 months.
Last raise 4.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 95% of Healthtech peers (2138 compared).
Modeled value ranks above 96% of those peers.
Closest niche peers: Freedom Dental Funding, LLC, Elevate Care International Topco LP, Athelas Inc., Health Gorilla, Inc., Employee Health Holdings, LP.
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.